Inovalis Real Estate Investment Trust Company Profile (TSE:INO)

Analyst Ratings

Consensus Ratings for Inovalis Real Estate Investment Trust (TSE:INO) (?)
Ratings Breakdown: 1 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: N/A

Analysts' Ratings History for Inovalis Real Estate Investment Trust (TSE:INO)
Show:
DateFirmActionRatingPrice TargetActions
5/25/2016National Bank FinancialDowngradeOutperform Market Weight -> Sector Perform Market WeightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016DesjardinsDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Inovalis Real Estate Investment Trust (TSE:INO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/18/2014$0.22$0.22ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2014$0.20$0.23ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/22/2014$0.20$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Inovalis Real Estate Investment Trust (TSE:INO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.25$0.25$0.25
Q2 20162$0.23$0.24$0.24
Q3 20162$0.23$0.25$0.24
Q4 20161$0.25$0.25$0.25
Q1 20171$0.25$0.25$0.25
Q2 20171$0.26$0.26$0.26
Q3 20171$0.26$0.26$0.26
Q4 20171$0.26$0.26$0.26
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Inovalis Real Estate Investment Trust (TSE:INO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Inovalis Real Estate Investment Trust (TSE:INO)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headlines for Inovalis Real Estate Investment Trust (TSE:INO)
No headlines for this company have been tracked by MarketBeat.com

Social

About Inovalis Real Estate Investment Trust

Inovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: INO
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $N/A
  • 200 Day Moving Average: $N/A
  • P/E Ratio: N/A
  • P/E Growth: N/A
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $ EPS
  • Next Year EPS Consensus Estimate: $ EPS
Additional Links:
Inovalis Real Estate Investment Trust (TSE:INO) Chart for Thursday, July, 28, 2016